Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

The U.S. Federal Deposit Insurance Corporation is proposing imposing new restrictions on investment giants BlackRock ...

Here’s an eight-step guide to launching an ETF: What qualifies as a viable idea will differ based on the needs and outlook of ...

This is for the sake of peace and security in Nigeria. Stop this drift towards national disintegration and anarchy now’’, ...

Shares of Charles Schwab (NYSE: SCHW), the brokerage powerhouse that recently surpassed Vanguard to become the largest ...

Exchange-traded funds manage your money passively with low fees, but a sea change within the industry is breathing life into ...

Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to ...

Additionally, both companies posted strong Q2 results in that time frame, with Microsoft delivering 15% year-over-year ...

The Indian subsidiary of South Korean automaker Hyundai Motor Company (HMC) allocated 42.4 million shares to 225 funds at ...

Fintel reports that on October 15, 2024, Keybanc downgraded their outlook for Lennox International (NYSE:LII) from Overweight ...

There are no directors' trades from Vanguard Australian Shares High Yield ETF (VHY). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

The market climbed a wall of worry to finish up the month of September, with the S&P 500 index gaining 2.1%, compared to a 0.1% loss for the Model Shadow Stock Portfolio.